DataMEDS AI, Inc. (MEDS)
NASDAQ: MEDS · Real-Time Price · USD
2.090
+1.225 (141.53%)
Sep 15, 2026, 2:48 PM EDT - Market open

DataMEDS AI Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
8.0223.3418.13--
Revenue Growth
-78.16%28.73%---
Gross Profit
-7.27-6.431.77--
Operating Income
-57.71-81.19-6.15-2.88-0.02
Net Income
-88.28-101.27-6.86-2.9-0.02
Earnings Per Share
-43.73-71.33-7.25-3.24-
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
2.460.041.030-
Total Debt
32.6224.58250.35-
Net Cash (Debt)
-30.17-24.54-23.97-0.35-
Net Cash Growth
-----
Net Cash Per Share
-14.94-17.29-25.36-0.39-

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-13.74-10.86-1.22-0.35-
Free Cash Flow
-13.74-10.86-1.22-0.35-
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-90.64%-27.54%9.75%--
Operating Margin
-719.27%-347.91%-33.90%--
Pretax Margin
-1100.30%-433.95%-37.82%--
Profit Margin
-1100.30%-433.95%-37.82%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
0.331.72---